Lung cancer, Small cell lung cancer
Results
Phase 2
This trial looked at having olaparib as a for people with small cell lung cancer (SCLC). It was for people who already had one treatment and most or all of their cancer had gone away.
Cancer Research UK supported this trial. The trial was open for people to join between 2013 and 2015. The team published the results in 2022.
Recruitment start: 19 September 2013
Recruitment end: 30 November 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Penella Woll
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Sheffield Teaching Hospitals NHS Foundation Trust
This is Cancer Research UK trial number CRUK/10/037.
Last reviewed: 06 Oct 2024
CRUK internal database number: 6188
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
